These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 7968939
21. Evaluation of the phencyclidine-like discriminative stimulus effects of novel NMDA channel blockers in rats. Nicholson KL, Balster RL. Psychopharmacology (Berl); 2003 Nov; 170(2):215-24. PubMed ID: 12851738 [Abstract] [Full Text] [Related]
22. Phencyclidine- and dizocilpine-induced hyperlocomotion are differentially mediated. Ogren SO, Goldstein M. Neuropsychopharmacology; 1994 Nov; 11(3):167-77. PubMed ID: 7865098 [Abstract] [Full Text] [Related]
23. Selective interaction of nitric oxide synthase inhibition with phencyclidine: behavioural and NMDA receptor binding studies in the rat. Klamer D, Zhang J, Engel JA, Svensson L. Behav Brain Res; 2005 Apr 15; 159(1):95-103. PubMed ID: 15795002 [Abstract] [Full Text] [Related]
24. Pharmacological mechanisms mediating phencyclidine-induced apoptosis of striatopallidal neurons: the roles of glutamate, dopamine, acetylcholine and corticosteroids. Griffiths MR, Cooper AJ, Barber DJ, Mitchell IJ. Brain Res; 2000 Feb 07; 855(1):1-10. PubMed ID: 10650124 [Abstract] [Full Text] [Related]
25. A comparison of the reinforcing efficacy of PCP, the PCP derivatives TCP and BTCP, and cocaine using a progressive ratio schedule in the rat. French ED, Lopez M, Peper S, Kamenka JM, Roberts DC. Behav Pharmacol; 1995 Apr 07; 6(3):223-228. PubMed ID: 11224330 [Abstract] [Full Text] [Related]
26. Electrical but not chemical kindling increases sensitivity to some phencyclidine-like behavioral effects induced by the competitive NMDA receptor antagonist D-CPPene in rats. Wlaź P, Ebert U, Potschka H, Löscher W. Eur J Pharmacol; 1998 Jul 24; 353(2-3):177-89. PubMed ID: 9726648 [Abstract] [Full Text] [Related]
27. Sensitive and rapid behavioral differentiation of N-methyl-D-aspartate receptor antagonists. Ginski MJ, Witkin JM. Psychopharmacology (Berl); 1994 May 24; 114(4):573-82. PubMed ID: 7855218 [Abstract] [Full Text] [Related]
28. The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents. Bristow LJ, Hutson PH, Thorn L, Tricklebank MD. Br J Pharmacol; 1993 Apr 24; 108(4):1156-63. PubMed ID: 8485625 [Abstract] [Full Text] [Related]
29. Discriminative stimulus effects of ethanol: effect of training dose on the substitution of N-methyl-D-aspartate antagonists. Grant KA, Colombo G. J Pharmacol Exp Ther; 1993 Mar 24; 264(3):1241-7. PubMed ID: 8450461 [Abstract] [Full Text] [Related]
30. Different capability of N-methyl-D-aspartate antagonists to elicit EEG and behavioural phencyclidine-like effects in rats. Sagratella S, Pezzola A, Popoli P, Scotti de Carolis AS. Psychopharmacology (Berl); 1992 Mar 24; 109(3):277-82. PubMed ID: 1365627 [Abstract] [Full Text] [Related]
31. Non-competitive N-methyl-D-aspartate antagonists are potent activators of ventral tegmental A10 dopamine neurons. French ED, Ceci A. Neurosci Lett; 1990 Nov 13; 119(2):159-62. PubMed ID: 2280889 [Abstract] [Full Text] [Related]
32. Decreased sensory responsiveness of noradrenergic neurons in the rat locus coeruleus following phencyclidine or dizocilpine (MK-801): role of NMDA antagonism. Murase S, Nisell M, Grenhoff J, Svensson TH. Psychopharmacology (Berl); 1992 Nov 13; 109(3):271-6. PubMed ID: 1365626 [Abstract] [Full Text] [Related]
33. NMDA receptor complex antagonists have ethanol-like discriminative stimulus effects. Colombo G, Grant KA. Ann N Y Acad Sci; 1992 Jun 28; 654():421-3. PubMed ID: 1385933 [No Abstract] [Full Text] [Related]
34. The phencyclidine (PCP) analog N-[1-(2-benzo(B)thiophenyl) cyclohexyl]piperidine shares cocaine-like but not other characteristic behavioral effects with PCP, ketamine and MK-801. Koek W, Colpaert FC, Woods JH, Kamenka JM. J Pharmacol Exp Ther; 1989 Sep 28; 250(3):1019-27. PubMed ID: 2674416 [Abstract] [Full Text] [Related]
35. Phencyclidine increases forebrain monoamine metabolism in rats and monkeys: modulation by the isomers of HA966. Jentsch JD, Elsworth JD, Redmond DE, Roth RH. J Neurosci; 1997 Mar 01; 17(5):1769-75. PubMed ID: 9030635 [Abstract] [Full Text] [Related]
36. Dendritic glutamate-induced bursting in the prefrontal cortex: further characterization and effects of phencyclidine. Shi WX, Zhang XX. J Pharmacol Exp Ther; 2003 May 01; 305(2):680-7. PubMed ID: 12606677 [Abstract] [Full Text] [Related]
37. The role of NMDA and sigma systems in the behavioral effects of phencyclidine in preweanling rats. Scalzo FM, Burge LJ. Neurotoxicology; 1994 May 01; 15(1):191-200. PubMed ID: 8090359 [Abstract] [Full Text] [Related]
38. Effects of antipsychotic treatments and D-serine supplementation on the electrophysiological activation of midbrain dopamine neurons induced by the noncompetitive NMDA antagonist MK 801. Bennett S, Gronier B. Synapse; 2007 Aug 01; 61(8):679-88. PubMed ID: 17523181 [Abstract] [Full Text] [Related]
39. Involvement of sigma receptors in the modulation of the glutamatergic/NMDA neurotransmission in the dopaminergic systems. Gronier B, Debonnel G. Eur J Pharmacol; 1999 Mar 05; 368(2-3):183-96. PubMed ID: 10193654 [Abstract] [Full Text] [Related]
40. Characterization of phencyclidine-induced effects on neuropeptide Y systems in the rat caudate-putamen. Midgley LP, Bush LG, Gibb JW, Hanson GR. Brain Res; 1992 Oct 09; 593(1):89-96. PubMed ID: 1360868 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]